InvestorsHub Logo
icon url

cannonball2010

07/12/05 8:19 AM

#622 RE: bocxman #621

Boxcman,Biocurex is not for sale.


Semi’s the word.

That brings us to the term ‘semi-exclusive’ within Tuesday’s release. Biocurex, for obvious reasons, is loath to grant exclusivity to any one company. Top-tier companies such as Abbott historically tend to want exclusivity. The fact that Abbott entered into a semi-exclusive arrangement, leaving Biocurex the right to enter into licensing arrangements with other companies, we believe, evidences the potential it sees in the technology and further enforces RECAF’s™ viability.


icon url

longterm42

07/12/05 10:13 AM

#623 RE: bocxman #621

BOCXMAN0: i agree. but i was thinking more around 500mil. & up. LT